The blog explores how Decentralized Clinical Trials (DCTs) are transforming clinical research by bringing studies directly to patients through digital technologies, telemedicine, and remote data collection. As this model grows, Medical Affairs plays a pivotal role in interpreting decentralized data, maintaining scientific integrity, and ensuring patient-centric innovation. The article highlights how DCTs and Medical Affairs together are shaping a future of continuous, data-driven, and equitable clinical evidence generation.